Literature DB >> 18472935

Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1.

E Helset1, T Sildnes, Z S Konopski.   

Abstract

In the present study we examined whether endothelin-1 stimulation of human monocytes causes release of chemotactic factors. It was found that monocytes released neutrophil- and monocyte-chemotactic activity in a dose- and time-dependent manner in response to ET-1. ET-1 did not show any chemotactic activity by itself. NCA was detected in monocyte supernatants in response to ET-1 (0.01-100 nM) after 1, 4, 8 and 24 h stimulation. MCA was detected only after 24 h stimulation with ET-1 (0.1-100 nM). Preincubation of the monocyte cultures with the lipoxygenase inhibitors nordihydroguaiaretic acid (10(-4) M) or diethylcarbamazine (10(-9) M) completely abolished the appearance of NCA and MCA. NCA was neutralized by > 75% using a polyclonal antibody against human interleuktn-8. The ET-1 induced release of IL-8 was confirmed by IL-8 ELISA. A monoclonal antibody against human monocyte chemotactic protein-1 neutralized MCA by > 80%. It is concluded that ET-1 stimulation of monocytes in vitro causes release of neutrophil- and monocyte-chemotactic activity identified as IL-8 and MCP-I respectively. An intact lipoxygenase pathway is crucial for this effect of ET-1 to occur.

Entities:  

Year:  1994        PMID: 18472935      PMCID: PMC2367024          DOI: 10.1155/S0962935194000207

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  20 in total

Review 1.  Nonspecific defence mechanism: the role of nitric oxide.

Authors:  F Y Liew; F E Cox
Journal:  Immunol Today       Date:  1991-03

2.  Delineation of the mechanism of inhibition of human T cell activation by PGE2.

Authors:  R Minakuchi; M C Wacholtz; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.

Authors:  S J Green; M S Meltzer; J B Hibbs; C A Nacy
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

4.  Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.

Authors:  P E Poubelle; D Gingras; C Demers; C Dubois; D Harbour; J Grassi; M Rola-Pleszczynski
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

5.  cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: the degree of inhibition correlates inversely with the amount of CD3 binding ligand used.

Authors:  N Papadogiannakis; T E Nordström; L C Andersson; C H Wolff
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

6.  Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.

Authors:  F Y Liew; S Millott; C Parkinson; R M Palmer; S Moncada
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

7.  Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives.

Authors:  J Mauël; A Ransijn; Y Buchmüller-Rouiller
Journal:  J Leukoc Biol       Date:  1991-01       Impact factor: 4.962

8.  Immunopathology of experimental cutaneous leishmaniasis.

Authors:  Z A Andrade; S G Reed; S B Roters; M Sadigursky
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

Review 9.  Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function.

Authors:  R M Locksley; P Scott
Journal:  Immunol Today       Date:  1991-03

10.  Differential effects of prostaglandins on macrophage activation induced by calcium ionophore A23187 or IFN-gamma.

Authors:  Y Buchmüller-Rouiller; S Betz-Corradin; J Mauël
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

View more
  8 in total

Review 1.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

Review 2.  Vascular endothelial dysfunction and pharmacological treatment.

Authors:  Jin Bo Su
Journal:  World J Cardiol       Date:  2015-11-26

3.  Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C.

Authors:  Vladimir Kuklin; Mikhail Kirov; Mikhail Sovershaev; Thomas Andreasen; Ole C Ingebretsen; Kirsti Ytrehus; Lars Bjertnaes
Journal:  Crit Care       Date:  2005-03-14       Impact factor: 9.097

4.  The TNF Receptors p55 and p75 Mediate Chemotaxis of PMN Induced by TNFalpha and a TNFalpha 36-62 Peptide.

Authors:  O Rekdal; Z Konopski; J S Svendsen; J O Winberg; T Espevik; B Osterud
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

5.  Nur77 attenuates endothelin-1 expression via downregulation of NF-κB and p38 MAPK in A549 cells and in an ARDS rat model.

Authors:  Yujie Jiang; Yi Zeng; Xia Huang; Yueqiu Qin; Weigui Luo; Shulin Xiang; Suren R Sooranna; Liao Pinhu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-07       Impact factor: 5.464

Review 6.  Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.

Authors:  Giuseppe Milone; Claudia Bellofiore; Salvatore Leotta; Giulio Antonio Milone; Alessandra Cupri; Andrea Duminuco; Bruno Garibaldi; Giuseppe Palumbo
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

Review 7.  Paracrine Role of the Endothelium in Metabolic Homeostasis in Health and Nutrient Excess.

Authors:  Cheukyau Luk; Natalie J Haywood; Katherine I Bridge; Mark T Kearney
Journal:  Front Cardiovasc Med       Date:  2022-04-26

Review 8.  Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.